ABOUT US
Board of directorsHans T. Schambye
Christian Hansen
Florian Schönharting
Torsten Goesch
Wyle Solomon
Management
Scientific advisors
Investors
Hans T. Schambye, MD, PhD
Chairman
Hans Schambye joined ReceptIcon in 2006 as Chief Executive Officer. Read more.
Christian Hansen, PhD, MBA
Board member
Christian Hansen is co-founder and partner of Nordic Biotech. Read more.
Florian Schönharting, MSc
Board member
Florian Schönharting is co-founder and partner of Nordic Biotech. Read more.
Torsten Goesch, MD, PhD, MBA
Board member
Dr. Goesch is a director of BioScience Managers Limited (BML) which he joined in July 2002. Read more.
Wyle Solomon , MSc, MBA
Board member
Wyle Solomon is Vice President at Nordic Biotech. He came to Nordic Biotech in June 2007 with over 15 years experience in pharmaceutical development, regulatory affairs and commercial & business development obtained through leadership positions at large, mid-sized, and start-up pharmaceutical companies.
Wyle was formerly employed by Mylan where he initially directed the regulatory affairs function for a specialty pharmaceutical division located in Vermont. Concurrent to completing his MBA in 2006, he moved into Commercial and Business Development where he was responsible for identifying and analyzing market and project opportunities and the development and maintenance of alliances.
Wyle previously headed the regulatory affairs and pharmaceutical development functions at Achillion Pharmaceuticals in Connecticut, and held positions of increasing responsibility at Bristol-Myers Squibb in New Jersey, as a scientist in oncology drug discovery and in regulatory affairs.
Wyle holds an MSc from Temple University School of Pharmacy in Pennsylvania and an MBA from McGill University School of Management in Montreal.
